Literature DB >> 18353948

Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccharides.

Jinglin Sun1, Jian Hua Zheng, Mengliang Zhao, Sunhee Lee, Harris Goldstein.   

Abstract

Inflammatory mediators and viral products produced by human immunodeficiency virus (HIV)-infected microglia and astrocytes perturb the function and viability of adjacent uninfected neuronal and glial cells and contribute to the pathogenesis of HIV-associated neurocognitive disorders (HAND). In vivo exposure to lipopolysaccharide (LPS) activates parenchymal microglia and astrocytes and induces cytokine and chemokine production in the brain. HIV-infected individuals display increased circulating LPS levels due to microbial translocation across a compromised mucosa barrier. We hypothesized that HIV-infected microglia and astrocytes display increased sensitivity to the proinflammatory effects of LPS, and this combines with the increased levels of systemic LPS in HIV-infected individuals to contribute to the development of HAND. To examine this possibility, we determined the in vivo responsiveness of HIV-infected microglia and astrocytes to LPS using our mouse model, JR-CSF/human cyclin T1 (JR-CSF/hu-cycT1) mice, which are transgenic for both an integrated full-length infectious HIV type 1 (HIV-1) provirus derived from the primary R5-tropic clinical isolate HIV-1(JR-CSF) regulated by the endogenous HIV-1 long terminal repeat and the hu-cycT1 gene under the control of a CD4 promoter. In the current report, we demonstrated that in vivo-administered LPS more potently activated JR-CSF/hu-cycT1 mouse microglia and astrocytes and induced a significantly higher degree of monocyte chemoattractant protein production by JR-CSF/hu-cycT1 astrocytes compared to that of the in vivo LPS response of control littermate mouse microglia and astrocytes. These results indicate that HIV infection increases the sensitivity of microglia and astrocytes to inflammatory stimulation and support the use of these mice as a model to investigate various aspects of the in vivo mechanism of HIV-induced neuronal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353948      PMCID: PMC2395169          DOI: 10.1128/JVI.02618-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

Authors:  Y Koyanagi; W A O'Brien; J Q Zhao; D W Golde; J C Gasson; I S Chen
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

2.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

3.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.

Authors:  M Piatak; K C Luk; B Williams; J D Lifson
Journal:  Biotechniques       Date:  1993-01       Impact factor: 1.993

4.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

Review 5.  Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.

Authors:  Yuri Persidsky; Howard E Gendelman
Journal:  J Leukoc Biol       Date:  2003-11       Impact factor: 4.962

Review 6.  Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.

Authors:  L G Epstein; H E Gendelman
Journal:  Ann Neurol       Date:  1993-05       Impact factor: 10.422

7.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice.

Authors:  Donna L Herber; Lisa M Roth; David Wilson; Nedda Wilson; Jerimiah E Mason; Dave Morgan; Marcia N Gordon
Journal:  Exp Neurol       Date:  2004-11       Impact factor: 5.330

9.  Microglia from mice transgenic for a provirus encoding a monocyte-tropic HIV type 1 isolate produce infectious virus and display in vitro and in vivo upregulation of lipopolysaccharide-induced chemokine gene expression.

Authors:  Emilie-Jeanne Wang; Jinglin Sun; Massimo Pettoello-Mantovani; Christina M Anderson; Kristin Osiecki; Meng-Liang Zhao; Lillie Lopez; Sunhee Choi Lee; Joan W Berman; Harris Goldstein
Journal:  AIDS Res Hum Retroviruses       Date:  2003-09       Impact factor: 2.205

10.  Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.

Authors:  R J Pomerantz; M B Feinberg; D Trono; D Baltimore
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

2.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

3.  Negative regulation of human astrocytes by interferon (IFN) α in relation to growth inhibition and impaired glucose utilization.

Authors:  Ting Wang; Yasuhiro Takikawa; Kei Sawara; Yuichi Yoshida; Kazuyuki Suzuki
Journal:  Neurochem Res       Date:  2012-05-25       Impact factor: 3.996

4.  Omega-3 fatty acids revert high-fat diet-induced neuroinflammation but not recognition memory impairment in rats.

Authors:  Aline Marcelino de Andrade; Marilda da Cruz Fernandes; Luciano Stürmer de Fraga; Marilene Porawski; Márcia Giovenardi; Renata Padilha Guedes
Journal:  Metab Brain Dis       Date:  2017-07-29       Impact factor: 3.584

Review 5.  Studies of retroviral infection in humanized mice.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Virology       Date:  2015-02-11       Impact factor: 3.616

Review 6.  Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Authors:  Christopher Power; Elizabeth Hui; Pornpun Vivithanaporn; Shaona Acharjee; Maria Polyak
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-15       Impact factor: 4.147

7.  Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy.

Authors:  Eric R Snook; Jeanne M Fisher-Perkins; Hope A Sansing; Kim M Lee; Xavier Alvarez; Andrew G MacLean; Karin E Peterson; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2013-12-04       Impact factor: 4.307

8.  The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1.

Authors:  Daniela Krause; Hyeon-Sook Suh; Leonid Tarassishin; Qiao Ling Cui; Bryce A Durafourt; Namjong Choi; Avital Bauman; Melissa Cosenza-Nashat; Jack P Antel; Meng-Liang Zhao; Sunhee C Lee
Journal:  Am J Pathol       Date:  2011-09       Impact factor: 4.307

9.  TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS.

Authors:  Hyeon-Sook Suh; Meng-Liang Zhao; Namjong Choi; Thomas J Belbin; Celia F Brosnan; Sunhee C Lee
Journal:  Virology       Date:  2009-07-30       Impact factor: 3.616

10.  Statin therapy inhibits remyelination in the central nervous system.

Authors:  Veronique E Miron; Simone P Zehntner; Tanja Kuhlmann; Samuel K Ludwin; Trevor Owens; Timothy E Kennedy; Barry J Bedell; Jack P Antel
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.